SPY326.97-3.68 -1.11%
DIA271.44-5.08 -1.84%
IXIC10,778.80-14.48 -0.13%

Wells Fargo Maintains Overweight on Evolent Health, Lowers Price Target to $17

Wells Fargo analyst Jamie Stockton maintains Evolent Health (NYSE:EVH) with a Overweight and lowers the price target from $19 to $17.

Benzinga · 01/08/2020 15:51

Wells Fargo analyst Jamie Stockton maintains Evolent Health (NYSE:EVH) with a Overweight and lowers the price target from $19 to $17.